Aryisulfonyichromas as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors

摘要

Compounds of the formula I: wherein m, n, p, X, Ar, R1, R2, R3, R4 and R5 are as defined herein. Methods of making the compounds and using the compounds for treatment of 5-HT6 receptor-mediated diseases are disclosed.